On 4/28/25, Dr. Sheel Patel in Fayetteville, NC, performed North Carolina's first CTAK inlay procedure, making a significant step forward in enhancing patient care, and offering new hope for patients in need of vision restoration. 

The Corneal Tissue Addition Keratoplasty (CTAK) clinic study began its first clinical trials at the Cornea and Laser Eye Institute in 2016. This procedure was developed as an innovative treatment for keratoconus, utilizing customized, laser-cut corneal tissue to improve vision and address structural irregularities in patients’ corneas. 

“Keratoconus can significantly disable patients by limiting their ability to drive and work.   After years of treating keratoconus with corneal crosslinking, intacs, and corneal transplantation, it has truly been a game-changer to incorporate CTAK to the armamentarium.   We can now simultaneously stabilize the disease process and improve patients’ visual acuity.” 

Several advantages of the CTAK procedure vs traditional treatments include a much lower risk of rejection, reduced distortion, and a much faster recovery time compared to full-thickness corneal transplantation.  Even more importantly, this partial-thickness treatment is significantly safer and less invasive both short-term and long-term when compared to full-thickness transplantation. Tissue inlay can also be removed or replaced if deemed necessary, offering more flexibility. 

This procedure is a good option for patients with keratoconus seeking improved vision and a more stable corneal shape.  CTAK is suitable for patients with mild to advanced keratoconus, including those with thinner corneas and very steep cones. 

The decision to undergo CTAK is made by an experienced ophthalmologist who specializes in corneal procedures. Your ophthalmologist will determine if you are a suitable candidate based on factors such as the severity and location of the cone, the thickness of your cornea, and your overall eye health.

To learn more visit: www.capefeareye.com